Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGMA: Magnesium for Alcohol Withdrawal Syndrome
NCT03033823Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2017
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium in alcohol withdrawal syndrome (AWS), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2017; status: completed.
02
Drugs
magnesium
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT03033823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033823.